Belpointe Asset Management LLC West Pharmaceutical Services Inc Transaction History

Belpointe Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$338.27 - $413.0 $550,365 - $671,951	1,627 New	1,627 $643,000
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $368,280 - $548,808	1,584 Added 569.78%	1,862 $645,000
Q4 2022 Feb 08, 2023	BUY	$209.34 - $261.61 $58,196 - $72,727	278 New	278 $65,000
Q2 2022 Aug 02, 2022	BUY	$280.61 - $420.45 $99,616 - $149,259	355 Added 30.9%	1,504 $454,000
Q1 2022 Apr 28, 2022	BUY	$357.49 - $445.92 $319,596 - $398,652	894 Added 350.59%	1,149 $472,000
Q4 2021 Feb 15, 2022	BUY	$402.25 - $471.34 $5,229 - $6,127	13 Added 5.37%	255 $119,000
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $87,848 - $113,369	242 New	242 $103,000
Q2 2021 Aug 09, 2021	SELL	$284.77 - $363.2 $701,673 - $894,924	-2,464 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$257.29 - $307.53 $633,962 - $757,753	2,464 New	2,464 $694,000
Q3 2020 Nov 13, 2020	SELL	$224.99 - $288.02 $516,352 - $661,005	-2,295 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$149.8 - $227.17 $343,791 - $521,355	2,295 New	2,295 $522,000

806

66M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.